NCT04982874View on ClinicalTrials.gov

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 13, 2019

Primary Completion Date

January 17, 2020

Study Completion Date

January 29, 2020

Conditions
Drug Use
Interventions
DRUG

Furosemide 40 mg

Administered with 240 mL of water

DRUG

Lasix® 40 mg Tablet

Administered with 240 mL of water

Trial Locations (1)

10520

PT Pharma Metric Labs, Jakarta Pusat

All Listed Sponsors
collaborator

PT Pharma Metric Labs

INDUSTRY

lead

PT. Kimia Farma (Persero) Tbk

INDUSTRY

NCT04982874 - Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers | Biotech Hunter | Biotech Hunter